Aquestive Therapeutics (AQST)'s 30-day implied volatility (IV30) was 68.1% at the close on November 2, 2026, up from 61.8% the day before, against a 52-week range of 42.7% to 245.9%. Its 20-day historical volatility was 60.2%.
Data as of November 2, 2026.